Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varicella Vaccine in Pediatric Liver Transplant Recipients
NCT00492739Phase 3Recruiting
- Start
- Jun 2007
- Primary completion
- Apr 2022
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of varicella virus vaccine live in varicella (VZV). Primary endpoint: Safety of VZV vaccine in OLTx recipients at 2 years. Started Jun 2007; status: recruiting.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00492739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492739.